InvestorsHub Logo
Followers 205
Posts 9789
Boards Moderated 6
Alias Born 10/02/2010

Re: namtae post# 18230

Sunday, 08/19/2018 12:19:17 AM

Sunday, August 19, 2018 12:19:17 AM

Post# of 21373
LOL, namtae…nonsense.

About 1 billion shares outstanding fully diluted



Uhhhh, Nope, that is incorrect.

104,477,936 O/S as of December 31, 2017 and 104,477,936 June 30, 2018, according to SEC filing 10Q filed 8/9/2018 for period ending June 30, 2018.

Even if you took all of the preferred convertibles and warrants that are convertible into common shares, it wouldn’t be 1B shares.

That’s my math based on filings. If your math contradicts mine, please correct me and source your claims.

toxic debt piling up and antidilutive securities readying to dilute common shareholders even further



Really? Please explain why note holders would agree to renegotiate the 2017 notes.

The maturity of the 2017 Notes was extended to 2019.

"...The convertible notes bear interest at a rate of 10% per annum, with accrued interest payable commencing April 1, 2019, then on the first day of each calendar month thereafter until maturity..."

Why would note holders agree to such terms if this claim was true?

Not a word about the clinicals that have been a disaster. No doubt about it.



Really? Note holders and insiders would appear to disagree with such a claim.

After the RS, this will be trading well below one penny.



Really? Doesn’t a R/S by default, raise the PPS by the appropriate ratio assigned by the terms of an R/S?

An R/S fictional scenario BTW that I believe to based on nonsense and incorrect information.

One day its “news soon, don’t miss out.”

The next day its “R/S soon, don’t get caught.”

Could you provide clarification for a simpleton like me? The numbers and verifiable facts are awfully confusing.

TIA, IMO and FWIW.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.